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1. Introduction 
Video-Assisted Thoracic Surgery (VATS) has without doubt been the most significant 
advance in thoracic surgery over the past half century. No other single innovation has so 
totally revolutionized the way thoracic surgeons perform their craft, or so greatly improved 
the surgical experience for patients undergoing thoracic operations worldwide. 
In any surgical specialty, patients in the 21st Century are already well aware of the benefits 
of minimally invasive surgery. Thoracic surgery is no exception. Throughout the world, 
patients requiring major lung resection surgery are increasingly demanding that they 
receive VATS. The trend for ever increasing proportions of lung resections being performed 
with a VATS approach is inexorable. This is true around the globe, from Asia to Europe to 
North America. It is becoming ever more difficult for thoracic surgeons to justify not using a 
VATS in the face of overwhelming evidence for the benefits of this approach – not only in 
terms of reducing patient morbidity, but also in improving surgical outcomes. 
Yet behind the hype and glamour of VATS today, there are aspects of the approach that 
even many experienced thoracic surgeons tend to overlook. It is often forgotten that VATS 
was first used for major lung resection two decades ago. During its infancy, VATS 
lobectomy was often dismissed as a gimmick or a fad with only limited niche applicability 
in thoracic surgery as a whole. The story of how VATS lobectomy matured, developed and 
evolved over the past 20 years to become the mainstream approach it is today contains 
many lessons for the modern thoracic surgeon. These include: realizing the importance of 
accurately defining a minimally invasive surgical approach such as VATS; establishing 
reliable outcome measures to objectively validate its efficacy; and continuing efforts to 
improving its outcomes and affirm its role in modern clinical practice. 
This chapter aims to provide an overview of how VATS lobectomy has evolved over the 
past two decades from a minor novelty into a fundamental pillar of thoracic surgical 
practice. The many innovations made and insights gained during the maturation of the 
VATS approach have had profound influence on how thoracic surgery as a whole is 
practiced today.  
2. Historical background 
VATS surgeons worldwide have generally attributed the origination of thoracoscopic 
therapy to the Swedish physician Hans Christian Jacobaeus (Jacobaeus, 1910; Braimbridge, 
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2000; Sihoe & Yim, 2008). Towards the end of the 19th century, he first used a modified 
cystoscope to examine the pleural cavity under local anesthesia. Using a simple candle as a 
light source, Jacobaeus peered through the rigid tube to look inside the chest. He primarily 
used this technique of direct thoracoscopy technique to lyse adhesions in order to collapse 
the lungs as this was the prevailing treatment for tuberculosis at the time. This technique 
was adopted throughout Europe in the early decades of the 20th century. As this method of 
direct visualization through a tube has now become forever linked to the term 
‘thoracoscopy’, many VATS surgeons today resolutely refer to modern VATS as ‘Video-
Assisted Thoracic Surgery’ and never ‘thoracoscopic surgery’ (Lewis, 1996).  
The introduction of streptomycin in 1945, and ever improving medical treatment of 
tuberculosis spelled the end of a period of enthusiasm for traditional therapeutic 
thoracoscopy. It is only in the last few decades that interest in minimally invasive thoracic 
surgical therapy was rekindled by two key technological developments. First, the marriage 
of the rod lens with solid state video systems and micro-cameras in the early 1980s allowed 
a panoramic view of the hemithorax, instead of the previous tunnel-like vision with direct 
thoracoscopy. Second, the availability of new endoscopic instruments like the linear 
mechanical stapler opened up new vistas for a spectrum of diagnostic and therapeutic 
procedures. From these advances, Video-Assisted Thoracic Surgery (VATS) was born. The 
video-thoracoscope unit with its own light source provides a well-illuminated, magnified 
operative view of the thorax, providing very high resolution for details surpassing even that 
provided by conventional headlight and magnifying loops. Although initially used for 
simpler diagnostic purposes, the tremendous success of laparoscopic cholecystectomy in the 
mid-1980s gave impetus to surgeons to apply VATS for therapy of intra-thoracic conditions.   
Before long, the potential advantage of the VATS approach for reducing post-operative 
morbidity and pain began gaining widespread notice. The first major meeting on VATS was 
held in January 1992 in San Antonio, Texas in conjunction with the Society of Thoracic 
Surgeons meeting, representing the baptism of a newborn technique (Mack et al, 1993). Over 
the subsequent years, VATS has become established and developed in many centers in 
North America, Asia, Europe, Australia and South America (Yim et al, 1998a). Its 
applications as a diagnostic approach and as a therapeutic modality for benign thoracic 
diseases have now been firmly incorporated into mainstream thoracic surgery. Throughout 
the 1990s, VATS gradually became the approach of choice for thoracic procedures such as 
diagnosis of solitary lung nodules, diffuse pulmonary infiltrates and pleural disease; and 
simpler therapeutic procedures such as for pneumothorax and excisions of mediastinal 
lesions. With growing experience with the technique, it was inevitable that more complex 
pulmonary operations were being performed using VATS.  
3. The genesis of VATS lobectomy 
For one whole century since the first lung resection was performed in 1891 by Tuffier, the 
posterolateral thoracotomy - and less frequently the median sternotomy and the clam-shell 
incisions for bilateral pulmonary procedures - have been the preferred modes of surgical 
access (Braimbridge, 2000). Unfortunately, although these incisions generally provide good 
surgical exposure, they are also among the most painful incisions in all of surgery. The 
trauma of access is often described as worse than that of the procedure itself. It has been 
reported that 5% to 80% of patients experience significant levels of pain at two months or 
more after a standard thoracotomy (Rogers & Duffy, 2000; Karmakar & Ho, 2004). This pain 
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can persist in up to 30% of patients at 4 to 5 years after surgery. It has previously been 
suggested that the pain can result from a combination of skin incision, muscle splitting, rib 
fracturing, costo-chondral dislocation, pleural injury, diathermy burning, neuroma 
formation at the wound, and so on. Above all, many surgeons believe that the single most 
important element is the forcible spreading of the ribs during thoracotomy.  
The rationale for VATS pulmonary resection is that by using video technology to minimize 
the surgical access required, most of these pain-causing elements can be reduced, 
particularly rib-spreading. The challenge to the first pioneers of VATS lobectomy, however, 
was how to negotiate the delicate hilar structures – particularly the pulmonary arteries 
which can easily tear and bleed. Using the small access ports envisaged, innovative 
strategies or exquisite sill would be required to tackle the structures situated on the medial 
side of the lobe, often buried by overlying parenchyma and fused fissures. 
One of the first to report large series of lobectomies for lung cancer using the VATS 
approach was Dr Ralph Lewis (Lewis et al, 1992; Lewis, 1995). The technique his group 
described used 4 ports and explicitly called for the avoidance of rib-spreading. The 
mediastinal lymph nodes are excised, the fissures divided with endoscopic staplers, and the 
hilar structures skeletalized. The hilar structures (pulmonary artery, pulmonary vein and 
lobar bronchus) are then simultaneously stapled in their normal anatomic configuration 
using two firings of a stapler device. This bold but simple technique permitted efficient 
resection of a lung lobe in the early days of VATS when the intricate skills needed for 
conventional isolation-ligation of individual hilar structures via the small incision were still 
being developed. Even in the early 1990s, in his first 200 consecutive patients using this 
technique, Lewis claimed impressively short average operating times of 79.5 minutes and 
length of hospital stay of 3.07 days (Lewis & Caccavale, 2000). There was no mortality and 
minor complications were only noted in 13% of patients. Importantly, no patient developed 
a bronchopleural fstula despite the use of simultaneous stapling. After a mean follow-up of 
34 months, recurrence-free survival was claimed in 141 out of 171 patients with primary 
lung cancers (even though less than half had post-operative stage I disease), and 7 deaths 
were unrelated to neoplasm.  
However, despite such promising results, Lewis’ simultaneous stapling technique met with 
considerable skepticism from the more traditional-minded thoracic surgeons’ community 
(Pearson, 2000). Although Lewis and colleagues made a very sound argument that 
simultaneous stapling was a safe and even historically-proven technique for lobectomy 
(Lewis, 1995; Lewis & Caccavale, 2000), their approach failed to become established into the 
mainstream in the face of overwhelming conservatism. Since then, VATS lobectomy has 
generally conformed worldwide to the strategy of individual isolation-ligation of hilar 
structures. Nonetheless, Lewis’ simultaneous stapling technique has never been discredited 
on clinical evidence. It can achieve a quick and safe means of removing a lobe, and can still 
play a part in the surgeon’s armamentarium for selected patients when an expeditious 
lobectomy is required. 
The individual isolation-ligation strategy took over as the mainstream for VATS lobectomy 
subsequently. As the early VATS surgeons tackled the challenge of the hilar structures, the 
initial instinct was to apply the conventional individual isolation-ligation of open 
thoracotomy but using smaller wounds. This conventional approach involved dissection of 
the pulmonary vessels via the interlobar fissure first, then completing the fissures, and 
finally dividing the bronchus (Roviaro et al, 1993; Kirby et al, 1993; Yim et al, 1996). The 
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advantage of this strategy was that it was immediately familiar for conventional thoracic 
surgeons – all that was required was getting used to doing the same operation via smaller 
wounds. The anatomy and intra-thoracic views were essentially familiar, and this made it 
simpler for surgeons to take the leap into the unfamiliar world of video images. Again, early 
reported results were encouraging with low mortality and short hospital stays. 
 
 
Fig. 1. Professor Anthony Yim was a pioneer of VATS lobectomy in Asia, developing some 
of the fundamental techniques of this new surgical approach in the 1990s. His work played a 
pivotal role in establishing VATS lobectomy as a key pillar of modern thoracic surgery. As 
seen in this early photo from Hong Kong, the basic elements used in the early days of VATS 
would remain very familiar to the VATS surgeon of today. 
However, it was gradually realized that simply copying the open thoracotomy approach 
(hilum, then fissure, then bronchus) was not necessarily ideal when performing VATS 
(Roviaro et al, 2000). In particular, the relatively fixed positions of the delicate hilar vessels 
made them hazardous to isolate and ligate individually. The rigidity of the ribs, the 
narrowness of the intercostals spaces, and the lack of angulation of the early staplers meant 
that stapler insertion around the vessels were often difficult - sometimes perilous - 
undertakings. Some surgeons preferred traditional ligature of the vessels with thread, but 
this in turn can be limited by the difficulty of intracorporeal knotting through small 
incisions, especially in patients with deep chests or tight intercostals spaces. The problem is 
only partly solved with the use of specially designed knot-pushers (Yim & Lee, 1995). 
It was only gradually appreciated that the slightly different views and access presented 
during VATS may require slightly different surgical strategies compared to open 
thoracotomy. With a conventional postero-lateral thoracotomy, looking straight down into 
the chest while standing behind the patient made it logically to employ a fissure-first or a 
posterior-to-anterior dissection strategy. With VATS, where the camera is usually placed at 
a lower level than the working port(s), this is often more difficult. Instead, working in an 
anterior-to-posterior direction, tackling vein the artery then bronchus, seemed to work 
better. The pulmonary vein is almost always easiest to approach first with the video-
thoracoscope, with little overlying tissue obscuring it. Once divided, the pulmonary artery 
branches are usually easy to expose without having to dissect laboriously through often 
fused interlobar fissures. Indeed, adept use of the video-thoracoscope can make this 
dissection of the arteries from this more medial aspect of the lobe a much more feasible 
proposition than with open thoracotomy. Dr Robert McKenna was among the first to 
advocate such a strategy (McKenna, 1994), and the gradual acceptance of this approach as 
the mainstream meant that most VATS surgeons nowadays tend to stand anterior to the 
patient when performing a lobectomy, instead of behind the patient as during a lobectomy 
via postero-lateral thoracotomy. 
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By the mid-1990s, the basic technique of VATS lobectomy had become progressively better 
defined. Certain key concepts were becoming consolidated into the maxim of the VATS 
surgeon. The ribs were not to be spread. Hilar vessels were to be individually isolated and 
divided. The sequence of hilar dissection may differ from open surgery. It was also 
becoming evident that staplers were a quintessential component of a VATS lobectomy, even 
if conventional ligation and suturing could still be used in some cases. With the key 
ingredients in place, VATS lobectomy appeared set to take on the thoracic surgery world. 
4. The rise and fall of early VATS lobectomy 
In establishing any new surgical approach, it is first necessary to demonstrate its safety for 
patients. With VATS lobectomy, the results of early case series universally ranged from 
good to excellent. The overall surgical mortality of 0-2% for VATS compared favorably to 
the conventional technique (Yim et al, 1998a; McKenna et al, 1998; Sihoe & Yim, 2008). Major 
complications and post-operative morbidity from VATS resections are relatively uncommon 
(Yim & Liu 1996; Walker, 2000), and minor complication rates are no higher than with open 
thoracotomy. Tumor implantation following VATS was an early concern (Downey et al, 
1996). However, even in a series in which wound protection was not routinely carried out, 
port site recurrence was noted in only 0.26% (Parekh et al, 2001). This already low figure 
could be further minimized by routine use of a wound protector, gentle handling of tissue, 
and copious irrigation of the hemithorax prior to closure (Sihoe & Yim, 2008). Early studies 
further showed that VATS took similar operating times as open surgery, but consistently 
produced similar or lower levels of blood loss (Demmy & Curtis, 1999; Sugiura et al, 1999). 
In return for equivalent safety as open surgery, VATS delivered the promise of less post-
operative pain for patients. Early evidence confiermed that patients who undergo resections 
via the VATS approach experience less immediate post-operative pain than those having the 
thoracotomy approach. This has been documented in several large case controlled studies 
either by objective assessment in terms of analgesic requirements (Yim et al, 1996; Walker et 
al, 1996), or subjective assessment in terms of pain scoring, usually in the form of a visual 
analogue scale (Giudicelli et al, 1994; Yim et al, 1996; Demmy & Curtis, 1999). A trend for 
reduced post-operative analgesic requirement was also seen in early studies comparing 
VATS with thoracotomy for lobectomy (Kirby et al, 1995; Sugiura et al, 1999). The reduced 
pain translated into faster recovery, resulting in significantly shorter hospital stays and 
earlier return to pre-operative work or activities (Demmy & Curtis, 1999; Sugiura et al, 
1999). 
By the mid to late 1990s, there was already widespread interest in this minimally invasive 
approach to lung resection surgery. Although relatively few surgeons were actively 
performing lobectomies this way, the rise of VATS was strikingly reflected in the large 
volumes of publications in this field. By the turn of the century, the number of papers 
published in indexed journals on VATS or ‘thoracoscopic’ lobectomy was being counted in 
hundreds. It seemed that VATS lobectomy would soon replace open lobectomy in our 
specialty, so popular was the approach becoming in academic circles. However, this 
honeymoon period was abruptly brought to a halt. 
An early, small, multi-institutional, randomized, prospective study of lobectomy performed 
through VATS compared to thoracotomy showed no significant benefits for using VATS in 
terms of pain reduction (Kirby et al, 1995). In another cross-sectional, questionnaire-based 
study, Landreneau and colleagues reported that the incidence of chronic post-operative pain 
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at one year following VATS was also not different from thoracotomy (Landreneau et al, 
1994). Over the years, these studies have been frequently quoted by opponents of VATS to 
suggest that the benefits of VATS may not extend to the long-term or were not clinically 
important. Very soon, a number of similar papers followed suit, questioning whether VATS 
gave patients any real benefit at all. In a separate study comparing VATS and open 
lobectomy, no statistical differences could be found in the pain assessment after 1 week, nor 
were any differences detected between groups with respect to respiratory muscle strength or 
6-minute walking distance (Nomori et al, 2001). Without doubt, these reports slowed the 
general acceptance of VATS lobectomy by surgeons in some countries for a number of years. 
Unsurprisingly, a survey of the General Thoracic Surgery Club members in 1997 showed 
that the majority considered this application unacceptable (Mack et al, 1997). In that survey, 
60% of respondents used VATS less than 20% of the time and 38.1% expressed concern 
regarding overuse. In particular, several concerns were raised. First, the safety of fine 
anatomical dissection of the hilum in an essentially closed chest was questioned. Second, 
there was skepticism over the adequacy of clearance for oncological lung resections with 
curative intent. Third, although the short term benefits of VATS to patients were intuitively 
obvious, its long term advantages over conventional surgery remained unclear. Fourth, the 
relatively high costs of the endoscopic equipments and VATS-related consumables cast 
doubt on the cost-effectiveness of this. 
Clearly, before VATS lobectomy could progress further as a viable surgical option, these 
concerns needed to be fully addressed. The pleasant surprise was that not only did the 
subsequent soul-searching by VATS proponents overcome these obstacles, it also revealed a 
great deal about the fundamental principles of lung cancer surgery itself.  
5. Defining VATS lobectomy 
When contemplating why some reports of VATS were emerging showing poorer than 
expected outcomes, it soon became clear that not all those reports were describing the same 
operation. Careful comparison of published reports confirmed that the ‘VATS lobectomy’ 
being reported was not a unified technique, but several variations existed (Yim et al 1998b; 
Sihoe & Yim 2008). During the initial scramble to become the first to report results with this 
new surgical technique, this procedure was developed almost simultaneously at different 
centers, with each unit carrying its own characteristics (Braimbridge, 2000). Not 
surprisingly, they did so with little consensus over some details of the technique. For 
example, how long an incision does one allow for a utility "minithoracotomy" before it 
becomes a "thoracotomy"? How often should one operate through the minithoracotomy as 
opposed to the video monitor? How much rib spreading can we afford before the benefits of 
minimal access surgery are lost?  
As a result of this lack of standardization in defining the VATS lobectomy procedure, some 
authors had been loosely applying the term “VATS” to describe any thoracic surgery in 
which a video-thoracoscope is prepared, often for little more than illumination of the 
thoracic space while the operation is performed essentially via an open approach (Yim et al 
1998b). In some instances, some authors were even tolerating a degree of rib-spreading 
when performing supposed ‘VATS lobectomy’ (Nomori et al, 2001). The number and 
position of ports used also varied considerably between centers. At first, the VATS 
community was very tolerant of such variations (Sihoe & Yim 2008). After all, the thinking 
went, how did it matter whether the surgeon was looking at the monitor throughout the 
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operation or frequently chose to peek through the wounds directly? As it turned out, it 
mattered a great deal. 
In a couple of landmark papers, Shigemura and colleagues compared three well-defined 
surgical approaches for lobectomy: ‘complete’ VATS (c-VATS) using purely endoscopic 
techniques with 100% monitor vision without rib-spreading minithoracotomy; ‘assisted’ 
VATS (a-VATS) performing the main procedures via rib spreading and using a 
minithoracotomy (10 cm long) with both monitor and direct vision; and open thoracotomy 
(20 cm long) with direct vision only (Shigemura et al, 2004 & 2006). In these studies, the 
average operative time was longer for c-VATS (246 ± 47 minutes) than for a-VATS (169 ± 27 
minutes) or open surgery (159 ± 28 minutes) (P < 0.05), but estimated blood loss was lower 
for c-VATS (96 ± 65 mL), and there was no significant difference in the number of dissected 
lymph nodes. Recovery time objectively analyzed by an accelerometer was shorter in 
patients undergoing c-VATS than in patients undergoing a-VATS or open surgery (p < 0.05). 
Median length of hospitalization was shorter for patients undergoing c-VATS (11.8 ± 2.7 
days) than for patients undergoing a-VATS and open procedures (P < 0.05). It was therefore 
elegantly demonstrated that strict adherence to a completely endoscopic approach could 
give measurably better outcomes. In effect, it became no longer possible to consider any 
compromise in technique (as in a-VATS) as acceptable when describing a proper VATS 
lobectomy. 
As a consequence of this realization, VATS surgeons have now applied much stricter 
definitions when describing VATS lobectomy. The Cancer and Leukemia Group B (CALGB) 
39802 trial of the American Society of Clinical Oncology has produced perhaps the most 
authoritative and accepted definition of the approach thus far (Swanson et al, 2007). In this 
trial of the safety and feasibility of c-VATS, VATS lobectomy has been defined by the 
following criteria: no rib spreading; a maximum length of 8 cm of the access incision for 
removal of the lobectomy specimen; individual dissection of the vein, arteries, and airway 
for the lobe in question; and standard node sampling or dissection (identical to an open 
thoracotomy). All specimens were placed in an impermeable bag and removed through the 
access incision. This definition carries the key points emphasized by the pioneers of VATS 
lobectomy to reduce surgical access trauma, filtering out ‘pseudo-VATS’ techniques that 
gave compromised results (Yim, 2002; Sihoe & Yim, 2008). However, it also allowed enough 
flexibility for individual surgeons to adapt the approach to their own tastes – as will be 
discussed below. 
Once the definition of VATS lobectomy was re-established, it became once more possible to 
clearly demonstrate the benefits of the minimally invasive approach over thoracotomy. 
Since the turn of the century, we have witnessed a second burst of publications espousing 
the virtues of VATS, no less compelling than the first burst of the early to mid 1990s. A large 
systematic review of 39 papers involving over 6000 patients compared VATS with 
thoracotomy with the majority of those papers published since the turn of the century 
(Whitson et al, 2008). Acknowledging the CALGB definition of VATS lobectomy, this study 
once more reaffirmed that compared with thoracotomy, VATS lobectomy was associated 
with significantly shorter chest tube duration, shorter length of hospital stay, and improved 
survival at 4 years after resection. Furthermore, in a secondary analysis of data from the 
American College of Surgeons Oncology Group Z0030 randomized clinical trial comparing 
VATS with open lobectomy for lung cancer, it was also found that VATS gave advantages 
(Scott et al, 2010). In summary, VATS gave less atelectasis requiring bronchoscopy (0% vs 
6.3%, P = 0.035), fewer chest tubes draining for longer than 7 days (1.5% vs 10.8%; P = 0.029), 
and shorter median length of stay (5 days vs 7 days; P < 0.001). 
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Fig. 2. It is actually not difficult for the casual observer to distinguish whether ‘complete’ 
VATS or ‘assist’ VATS is being performed, even if the wounds appear very similar in size at 
the end of the operation. In ‘complete’ VATS (A), the surgeon operates using monitor vision 
exclusively and can therefore stand comfortably upright throughout the operation. Only 
gentle skin retraction is occasionally used at the utility port. In ‘assisted’ VATS (B), the 
surgeon operates some or most of the time using direct vision via the utility port and 
consequently is often seen stooping over the patient to ‘peek in’. To allow enough room for 
both direct vision and instrumentation through that port, some degree of rib retraction must 
typically be used. 
It is therefore confirmed that VATS gives clinical advantages once clearly defined. However, 
this in turn raises the question: ‘why?’ What is so special about the criteria used for defining 
VATS that they can significantly impact on outcomes? 
Looking at the four listed criteria of the CALGB definition, it is clear that the length of the 
main incision is not that important. Even when a large number of reports using a large 
range of wound lengths are considered together, the advantage of VATS over thoracotomy 
is well maintained (Whitson et al, 2008). Neither is the use of individual isolation-ligation of 
the hilar structures that important – as evidenced by the excellent results reported by 
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surgeons using a simultaneous stapling technique (Lewis et al, 1992; Lewis, 1995). Even the 
extent of lymph node dissection is not the critical issue, as similar outcomes in terms of 
morbidity are seen regardless of how much dissecting is done (Sagawa et al, 2002; Watanabe 
et al, 2005; Denlinger et al, 2010). What is left of the CALGB criteria is therefore perhaps the 
most important: avoidance of rib-spreading. 
It has been demonstrated that pain or aching can occur in up to 50-70% of patients at two 
months or more after thoracotomy (Rogers & Duffy, 2000; Karmakar & Ho, 2004). In 5% of 
these patients, the pain has been described as ‘severe and disabling,’ and over 40% of 
patients may still have some degree of pain at one year after surgery. Patients with such 
post-thoracotomy pain typically describe their pain as being burning, aching, electrical 
and/or shock-like in quality (Benedetti et al, 1998a; Rogers & Duffy, 2000), and responding 
poorly to the use of opiates (Benedetti et al, 1998b).These characteristics are the same as 
those of recognized neuropathic pain syndromes, such as post-herpetic neuralgia and 
diabetic peripheral neuropathy (Nicholson, 2000; Laird & Gidal, 2000).  These all suggest 
that one of the key mechanisms of post-thoracotomy pain may be neuropathic. Specifically, 
the rib-spreading during thoracotomy may be causing substantial compression and hence 
neuropraxic damage to the intercostals nerves. Emerging physiological studies are now 
gradually confirming this hypothesis (Benedetti et al, 1998a; Rogers et al, 2002; Maguire et 
al, 2006; Bolotin et al, 2007). In turn, this means that the benefits of VATS over thoracotomy 
may to a large degree be explained by the eschewing of rib-spreading and intercostals nerve 
trauma. 
This understanding not only helps in lowering morbidity after thoracotomy (such as by 
increasing use of VATS), but also in improving outcomes after VATS itself. This is because 
VATS does not absolutely eliminate intercostal nerve trauma as will be discussed below, 
and this understanding gained by simply appreciating the fundamental definition of VATS 
may also help in its treatment.  
6. Improving the validation of outcomes following VATS lobectomy 
Besides honing of the definition of VATS lobectomy, another key factor in the resurgence of 
this surgical approach since the 1990s has been the improvement in quality of the clinical 
research published to investigate its worth.  
Following from the early success of laparoscopy in abdominal surgery, initial reports on 
VATS focused on the benefits it promised in terms of reduced pain with the smaller 
wounds. But how can pain be accurately assessed? Most clinical studies even today use 
patient self-reporting of levels of pain. The most common self-reporting tools are the Visual-
Analog Scale or a simple 10-point numeric score. These are very simple to use and readily 
understood by both patients and fellow clinicians. However, they are well recognized to be 
subject to a wide range of confounding variables. For example, these may include patient 
socio-economic factors, chronic pain or analgesic use pre-operatively, other sources of post-
operative satisfaction or dissatisfaction, and so on. The result is both a certain degree of 
unreliability and considerable variance in the scores collected. The latter in particular may 
have contributed to some of the more negative findings about VATS in the aforementioned 
studies of the mid and late 1990s (Landreneau et al, 1994; Kirby et al, 1995; Nomori et al, 
2001). Other methods to quantify pain directly are also problematic. More sophisticated pain 
scores – such as the McGill Pain Scale – have been suggested. However, these are not 
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tailored for use in post-operative patient, and they are often too complex and unwieldy to 
use in the setting of an acute surgical ward. Counting the use of analgesics is also not ideal. 
If a standardized post-operative protocol of regular analgesic is used, not enough difference 
may be shown between VATS and open patients. However, if a very flexible ‘as required’ 
analgesic regimen is used the results will again will be confounded by factors such as 
individual patient pain thresholds and prejudices about taken medications. Early reports 
describing such results also demonstrated that it is hard to compare results sometimes 
between different cohorts or studies. For example, does a VATS patient taking two tablets of 
a non-steroidal anti-inflammatory drug daily have more or less pain than a thoracotomy 
patient taking a total of 10 tablets of a mild opiate over five days? For all these reasons, early 
studies reporting the alleged benefits of VATS lobectomy came in for considerable criticism 
over the years. 
Learning from these lessons, VATS surgeons have taken to using surrogate measures of 
reduced morbidity. If pain is reduced, would this not be reflected in shorter hospital stays 
and earlier return to work? Again, almost every clinical study on VATS suggests that the 
minimally invasive approach shortens lengths of stay, but again such results are prone to 
bias. Although chest drain durations can be crudely regulated by defining drainage volume 
and air leak cessation criteria triggering removal, lengths of stay are much more subject to 
confounding variables such as clinician desire to send a VATS patient home or patient 
keenness or reluctance to leave hospital just days after major surgery. It is already 
recognized that, for example, that in general, the hospital length of stay in Asian institutions 
is longer than in North American institutions, reflecting the influence of cultural factors that 
undermines the usefulness of this outcome measure (Whitson et al, 2008). The same can 
apply to early reports using return to work to demonstrate the benefit of VATS. 
Further efforts to display the morbidity reduction with VATS are now coming to fruition 
though. One of the methods is to compare pre- and post-operative Quality of Life (QoL). 
There is increasing realization that post-operative QoL is very important to the cancer 
patient. It has been shown that patients tend to be more concerned about post-operative 
functional status and performance in activities of daily living than in abstract survival 
statistics (Cykert et al, 2000). On a more practical leveler for VATS researchers, many 
excellent and well-validated QoL assessment tools are widely available. One detailed survey 
used the EORTC QLQ-C30 and EORTC QLQ-LC13 questionnaires designed to assess QoL in 
lung cancer patients, supplemented by a self-designed, nine-item surgery-specific 
questionnaire (Li et al, 2002). The survey was conducted on patients who received lung 
resections with curative intent for early stage lung cancer either by a VATS approach 
(median follow-up time of 33.5 months) or by an open thoracotomy approach (39.4 months). 
Statistically comparable levels of QoL and functional status were noted in both groups, 
although there was a trend for the VATS group to show better QoL scores and lower 
incidences of fatigue, dyspnea, coughing, and pain. Since then, an increasing number of 
papers have confirmed that VATS offers patients better QoL following lobectomy than 
thoracotomy, providing a much more reliable, quantifiable proof of its advantage (Handy et 
al, 2010; Rueth & Andrade, 2010). 
Another important but often overlooked measure of both post-operative pain and QoL after 
thoracic surgery is the impairment of shoulder function following thoracic surgery. 
Shoulder function can be impaired following a thoracotomy by a combination of 
neurological injury during patient positioning, division of shoulder girdle muscles, direct 
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injury to the long thoracic nerve, and as a result of the significant post-operative pain from 
the wound. By reducing such surgical trauma and post-operative pain, VATS lung 
resections may reduce the incidence of post-operative shoulder dysfunction. Previous 
studies have reported that the strengths of the lattisimus dorsi and serratus anterior muscles 
may be better preserved following VATS when compared to thoracotomy (Landreneau et al, 
1993; Giudicelli et al, 1994). In a prospective study, Li et al reported that short-term shoulder 
strength and range of movement were significantly better in patients who received VATS 
pulmonary resection than those who received thoracotomy (Li et al, 2003). Again, such 
studies provide more objective evidence of morbidity reduction after VATS. 
There is emerging evidence that VATS causes less depression of pulmonary function after 
lung resection surgery than thoracotomy. Kaseda reported that both the forced expiratory 
volume in one second (FEV1) and forced vital capacity (FVC) values measured at three 
months post-operatively were significantly preserved relative to pre-operative values in 
patients who underwent lobectomy by a VATS approach compared to those receiving a 
thoracotomy approach (p<0.0001) (Kaseda et al, 2002). In another similar study, post-
operative PaO2, SaO2, peak flow rates, FEV1 and FVC were all found to be better on post-
operative days 7 and 14 in patients who had VATS rather than thoracotomy for lung 
resection (Nakata et al, 2000). Blood oxygenation, lung diffusion capacities, 6-minute walk 
test results, and recovery of vital capacity and cardio-pulmonary function after surgery all 
tend to be better after VATS than after various forms of open thoracotomy for pulmonary 
resections(Nagahiro et al, 2001; Nomori et al, 2002 & 2003a). 
The most exciting attempt to prove that VATS causes less trauma than thoracotomy have 
come from studies looking at the impact of surgery on inflammatory and immune 
markers. There is now a wealth of literature showing that the body’s immune function is 
better preserved following laparoscopic surgery compared to its open counterparts in 
general abdominal surgery. In thoracic surgery, one study has now demonstrated that 
patients with clinical stage I lung cancer undergoing VATS lobectomy had significantly 
reduced post-operative release of both pro-inflammatory (interleukins 6 and 8) and anti-
inflammatory cytokines (interleukin 10) into the plasma compared to those having 
conventional resection (Yim et al, 2000a). Similar findings were also reported in a smaller 
Japanese study which showed significantly reduced cytokine release (interleukins 6 and 8) 
into the pleural fluid in the VATS lobectomy group compared to the open group (Sugi et 
al, 2000a). In a small randomized, prospective study from Edinburgh, it was also shown 
that VATS lobectomy was associated with a lesser effect on the post-operative fall in 
circulating T (CD4) cells and natural killer (NK) cells (Leaver et al, 2000). Lymphocyte 
oxidation was also less suppressed by VATS compared to open surgery. The same group 
also found that a range of acute phase responses – including C-reactive protein, 
interleukin 6, tumor necrosis factor, P-selectin, and oxygen free radical activity – were also 
significantly less amongst the VATS patients (Craig et al, 2001). A separate Hong Kong 
study found that NK cell levels were suppressed to similar degrees on the first post-
operative day following both VATS and thoracotomy lung resections for non-small cell 
lung cancer, but that T lymphocyte numbers were significantly more reduced following 
thoracotomy (Ng et al, 2005). The levels of NK cells subsequently rose more quickly in the 
VATS group. These results suggest that the VATS approach was associated with less, and 
quicker recovery from, post-operative immunosuppression following lung resection 
surgery than the thoracotomy approach. 
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In essence, there is evidence now to believe that VATS is associated with less perturbation in 
both the humoral and cellular immune functions compared to open surgery, at least in the 
short term (Walker et al, 2000). So far, there have been no reports demonstrating that VATS 
pulmonary resection confers a lower incidence of post-operative infection than the open 
approach. It has also been hypothesized that as immunosurveillance may play an important 
role in the progression of cancer, surgically induced immunosuppression may predispose to 
increased tumor growth or recurrence. Whether better preservation of the immune system 
by VATS may lead to improved long term survival is unclear but certainly deserves further 
investigation (Yim, 2002). 
The ongoing quest to show the advantages of VATS lobectomy over open surgery has 
succeeded not only in emphatically meeting this primary objective, but also in teaching 
thoracic surgeons some valuable lessons. The need to find more reliable assessors for peri-
operative morbidity has been underscored. This in turn has focused attention on matters 
important to the patient – such as QoL and post-operative function – rather than just 
abstract statistics interesting to the surgeon. The extension of the quest to demonstrate less 
physiological harm to the body using VATS has also begun to highlight the potential 
oncologic advantage of VATS lobectomy – as will be discussed below. 
7. The oncologic efficacy of VATS lobectomy 
Critics of the VATS approach for lung cancer research will say – quite rightly – that all the 
above benefits of VATS are meaningless if the operation cannot fulfill its primary obligation 
to provide effective oncologic treatment. As mentioned above, the focus of these early 
doubts on the oncologic efficacy of VATS lobectomy included: whether VATS allowed fine 
anatomical dissection for individual isolation-ligation of the hilar structures; whether VATS 
was a cost-effective means of delivering oncologic therapy; and whether VATS gave 
adequate clearance for oncological lung resections (Mack et al, 1997). The concern over the 
ability of VATS to allow lobectomy using an individual isolation-ligation strategy has been 
resoundingly answered by almost two decades of successful surgery around the world. 
The question of cost-effectiveness arose because many centers initially baulked at the high 
consumables costs and potentially longer operating times involved in a typical VATS 
lobectomy. However, by choosing the right patients for this technique, using mainly 
conventional instruments, and relying on ligation and suturing in preference to staplers 
where possible, the consumable costs could be minimized (Yim, 1996). More importantly, 
VATS promises shorter hospital stays and fewer complications. The savings gained by the 
shorter stays and having to treat fewer complications tend to offset the higher consumables 
costs. One study comparing VATS versus open resections for cancer showed that the overall 
hospital charges were therefore possibly even lower when VATS is used(Nakajima et al, 
2000). In experienced hands, VATS major resection could also be as quick an operation as 
the open approach because less time is needed to open and close the chest. Most centers 
regularly performing VATS lobectomy no longer find any significant difference in operating 
times between VATS and open lobectomies (Sihoe & Yim, 2008). Nowadays, the challenge 
facing VATS lobectomy is ironically not the fear of higher consumables costs, but rather the 
expectation by patients and/or insurers of lower overall costs – which may even affect 
compensation for the surgeon in some regions. 
The question about whether VATS gives adequate oncologic clearance requires a more 
complex answer. After all, an anatomic lobectomy is an anatomic lobectomy whether it is 
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done by a minimally invasive or open approach. How is it possible to demonstrate whether 
a lobe resected by VATS is any more or less a lobe than one removed via thoracotomy? 
Instead, the battle of the adequacy of VATS is being waged not over the quantity of the lobe 
itself, but over the amount of lymph node tissue being resected. Opponents of VATS have 
long suggested that even if a lobe can be removed by VATS, the approach does not allow 
radical nodal clearance. The debate over the relative merits of lymph node sampling versus 
lymph node dissection after lung cancer resection is ongoing and beyond the scope of this 
chapter. However, even if radical nodal dissection is desired, there is now growing evidence 
that the adequacy of VATS radical lymphadenectomy approaches that of open surgery both 
in terms of number and mass of nodal tissue removed. In one study, an open thoracotomy 
immediately after VATS nodal dissection in the same patient could yield only 3% more 
nodal tissue – an insignificant amount (Sagawa et al, 2002). Two retrospective studies on 
non-contemporary cohorts of VATS and thoracotomy patients found that VATS gave similar 
or slightly less nodal tissue, but survival and staging were not affected (Watanabe et al, 
2005; Denlinger et al, 2010). In a more recent prospective study of contemporary VATS and 
thoracotomy cohorts, VATS was confirmed to yield at least as much nodal tissue as 
thoracotomy regardless of side, lobe or stage of the lung cancer (Sihoe et al, 2011). In 
addition, VATS gave higher yields at traditionally ‘trickier’ nodal stations such as the 
subcarinal nodes (possibly because of the better view VATS afforded in such areas), and the 
2-year recurrence-free survival was also higher with VATS. It therefore appears that 
anatomically-speaking there is no longer a case to suggest VATS is not as oncologically 
complete as open thoracotomy for lung cancer surgery. 
The last bastion of resistance against the adequacy of VATS lobectomy must therefore be 
long-term survival rates. Ultimately, any quantifiably proven similarity between VATS and 
thoracotomy intra-operatively must be translated into similar ‘cure’ rates post-operatively. 
Thankfully, a large volume of evidence has been accumulated over the past two decades in 
this regard. These have consistently demonstrated similar survival rates between VATS and 
open lobectomy patients (Sugi et al, 2000b; Rueth & Andrade, 2010). However, a trend has 
long been noticed by VATS surgeons for a trend of longer survival amongst VATS patients. 
Studies from Japan have time and again reported remarkable 5-year survival rates of around 
90% for stage IA lung cancer patients receiving VATS lobectomy (Sugi et al, 2000b; Kaseda 
et al, 2002; Watanabe et al, 2005). In a 2008 systematic review of 39 studies comparing VATS 
with open lobectomy, patients who underwent VATS lobectomy were finally confirmed to 
have improved survival versus patients with open lobectomy (88.4% vs 71%; p = 0.003) 
(Whitson et al, 2008). More recently, another similar systematic review reported that 5-year 
survival was significantly improved for patients who undergo VATS lobectomy for early-
stage NSCLC (VATS relative risk, 0.72; p = 0.04), further suggesting that VATS lobectomy is 
at least oncologically equivalent to open lobectomy (Yan et al, 2009).  
It is still premature to declare with certainty that VATS gives better survival than open 
lobectomy. Nonetheless, many surgeons have already begun to speculate over reasons why 
this phenomenon should be possible. The theory gaining most recent attention is that of the 
effect of VATS on peri-operative immuno-surveillance. It has been shown that tumor cells may 
be shed into the circulation during lung cancer surgery (Yamashita et al, 2000). In other 
surgical specialties, it has been demonstrated that the body’s own immune system can help kill 
or remove such circulating tumor cells – a process often called ‘immuno-surveillance’ (Shariat 
et al, 2002; Wu et al, 2002). In theory, if the body’s immune function is somehow impaired this 
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may inhibit the peri-operative removal of tumor cells shed during the operation, which can 
then manifest as subsequent recurrence or metastasis. It has already been mentioned above 
that studies now show that VATS causing less immune system disruption than open surgery. 
Therefore, according to this theory, it should be expected that VATS is associated with better 
long-term survival. At present, this remains fanciful speculation. However, given the 
impressive speed at which other advantages of VATS are being discovered, it would not be a 
surprise to see this theory corroborated by new evidence before too long. 
8. State of the art 
The VATS lobectomy that has established itself as a viable – if not superior – alternative 
surgical approach to open lobectomy is now practiced widely around the world. In some 
centers, such as in Hong Kong, VATS lobectomy has been routinely performed for the 
majority of patients with early stage lung cancer since the mid 1990s (Yim et al, 1996). As 
said above, other countries have taken up VATS lobectomy at a rather slower pace because 
of lingering doubts generated by the negative reports of the mid to late 1990s. Nonetheless, 
over the past several years, major centers several other countries have reached this 
landmark of over half of all lobectomies being performed using the VATS approach – 
notably the USA and South Korea. What is most noticeable about the current resurgence of 
VATS lobectomy compared to the initial rise in the early 1990s is that this time most 
surgeons are performing the operation according to the same consensus definition of what 
VATS lobectomy should be. The result is that operations in different centers around the 
world are now much more similar in the basic characteristics: no rib spreading; a single 
access incision for specimen retrieval; individual isolation-ligation of the vessels; and 
systematic nodal dissection. Thankfully, within this broad definition, there remains much 
scope for variations in the details as individual surgeons adapt their technique to their own 
preferences – some of which are worth mentioning here. VATS surgeons should never be 
too proud to refuse adapting the practices of others when they are suitable. 
Hong Kong was one of the earliest regions where VATS lobectomy was developed (Yim et 
al, 1998a). Professor Anthony Yim is undoubtedly the pioneer of this technique in Asia, and 
his groundbreaking work helped establish its role for lung cancer therapy worldwide. But as 
mentioned above, in these early days many pioneers strove to replicate open lobectomy via 
the small VATS incisions. Hence, the sequence of hilar structure dissection was essential 
unchanged from open surgery (Roviaro et al, 1993; Kirby et al, 1993; Yim et al, 1996). For 
VATS surgeons in Hong Kong, mediastinal lymph node sampling rather than systematic 
dissection was the norm, and it was initially deemed acceptable to operate whilst 
occasionally looking through the main wound. However, these practices soon changed. This 
author teaches surgical trainees that to operate inside the human chest, the surgeon must 
place three things inside the patient: his right hand, his left hand, and his pair of eyes. In 
open thoracotomy, the ribs must be spread apart to permit these three things to enter the 
patient’s chest. With VATS, instruments can replace the right and left hands, and the video-
thoracoscope can replace the surgeon’s eyes. In this way, rib-spreading can be totally 
avoided, giving the patient less surgical access trauma. However, if the surgeon still resorts 
to looking through the wounds to operate, the eyes must once again share access through 
one of the ports with the hand (or instruments). The only way this can be possible is if there 
is some rib-spreading, wound enlargement, and/or increasing torquing at the ports (see 
Figure 2). Any of these can negate the supposed benefits of VATS. 
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Therefore, since the 1990s, the practice of VATS lobectomy in Hong Kong has evolved. This 
author now strictly foregoes any form of direct vision through the wounds, and operates 
exclusively using video monitor visualization. The assistant is reminded to avoid torquing 
the video-thoracoscope via the camera port. Because of the leverage, even slight torquing 
could result in significant pressure on the intercostal nerve, causing post-operative neuralgia 
(Yim, 1995). The rigid plastic camera port can be slid back along the thoracoscope out of the 
wound after the thoracoscope is inserted into the chest, allowing more flexibility of the 
thoracoscope in the chest with less torquing at the wound (Sihoe & Yim, 2008). A three-port 
strategy is used, with two 10mm incisions for the camera and instruments respectively, and 
a third 4cm utility port in the fourth or fifth intercostals space (with no rib-spreading) for 
specimen retrieval. Both the surgeon and assistant stand anterior to the patient, and both 
watch the same video monitor throughout the operation, facilitating camera handling by the 
assistant (instructions from the surgeon are easier to follow without the hindrance of 
paradoxical movement or resorting to awkward camera orientations). Dissection is from an 
anterior-to-posterior direction, typically taking the pulmonary vein first, then pulmonary 
artery the bronchus. The fissures are taken last of all, and staplers are used in a ‘fissureless’ 
technique to minimize post-operative air leak (Nomori et al, 2003b). A systematic dissection 
at all the ipsilateral mediastinal lymph node stations in routinely carried out in all patients.  
 
 
Fig. 3. The photos show the author performing a VATS Left Pneumonectomy (hence the 
slightly long than usual utility port). (A) Both the surgeon and the assistant stand at the 
anterior of the patient. (B) The axis of the operation is in an antero-inferior to postero-superior 
direction as indicated by the arrow. The axis begins at the assistant, goes through the camera 
port (here used to place the chest drain at the end of the operation), and proceeds straight on to 
the video monitor. The surgeon ‘straddles’ the axis anterior to the assistant, with the right and 
left hands operating comfortably via ports placed either side of this axis. By sharing the same 
axis and the same monitor, there is better co-ordination between the two throughout the 
operation and paradoxical camera movements are minimized. 
www.intechopen.com
 
Topics in Thoracic Surgery 196 
This totally endoscopic c-VATS lobectomy performed in Hong Kong is essentially the same 
operation found throughout the world nowadays (McKenna et al, 2006; Kim et al, 2010). The 
basic techniques will be familiar to VATS surgeons from any country: no rib-spreading; 
surgeon standing anterior to the patient; an anterior-to-posterior strategy; fissureless 
surgery; and systematic exploration of the nodes. This approach can be summarized as the 
current state of the art. Certain detail variations exist of course, such as number and size of 
ports or extent of nodal dissection. However, some VATS surgeons deviate significantly 
from this basic technique in fine detail (whilst adhering to the same basic principles and 
definition of VATS lobectomy), and they have achieved success with their modifications. It 
is worthwhile to consider these variations. 
Instead of always standing at the anterior side of the patient, surgeons at several centers in 
Asia prefer always standing on the right side of the operating table for a VATS lobectomy, 
regardless of whether the operation is on the right or left lung. In other words, the surgeon 
would stand anterior to the patient for a left lung operation, but posterior to the patient for a 
right lung operation. The rationale for this is because for a right-handed surgeon, it is 
usually ergonomically more comfortable to reach around the patient with the dominant 
right arm and face the video monitor placed in a more cephalad direction. Proponents of 
this positioning claim that for the surgeon to stand on the left side of the table, the right arm 
can be tucked too close to the surgeon’s own body for comfortable operating. They claim 
that by always standing on the right side of the patient, back problems may also be possibly 
avoided. 
Dr Tadasu Kohno of Tokyo, Japan is another leading VATS surgeon in Asia who has 
developed a rather distinctive strategy for surgeon and assistant positioning (Mun & Kohno, 
2008). In this strategy, the surgeon stands posterior to the patient and the camera-holding 
assistant anterior to the patient. The camera is inserted in the port most anterior on the 
patient, with the other working ports closer to the surgeon. To ensure the correct orientation 
of the image on the video-monitor for the surgeon, the camera on the video-thoracoscope is 
turned so that ‘upwards’ on the camera and image is towards the anterior of the patient. 
Because the video-thoracoscope enters the chest via the most anterior camera port, this 
usually means the camera itself is held almost upside-down by the assistant. The advantage 
of this strategy is that it best approximates the surgeon’s position and views during a 
traditional open lobectomy via a postero-lateral thoracotomy. This facilitates the transition 
from open to VATS lobectomy for some surgeons. However, handling the camera in a 
virtually upside-down position on the opposite side of the operating table from the surgeon 
requires a very skilled and experienced assistant. 
Dr Dominique Gossot of Paris, France also describes an interesting approach to VATS 
lobectomy (Gossot, 2008). Like Dr Kohno, he also prefers the surgeon standing behind the 
patient. The peculiar feature of Dr Gossot’s technique is that he doesn’t create a utility or 
access port right at the beginning of the operation. He also does not use the more common 3-
port strategy. Instead, four to five ports are used to perform the entire operation, with ports 
sizes ranging from 3mm to 15mm. Only after the lobe has been resected is a utility port 
created for retrieval of the specimen. It is claimed that by leaving the utility port until the 
end of the operation, ‘use’ of this slightly longer incision is only for a brief time and surgical 
access trauma is minimized. Critics may claim that no rib-spreading is used in modern 
VATS lobectomy anyway so the size and duration of the utility port does not really 
contribute significantly to morbidity. Furthermore, whether a shorter duration of having a 
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utility port can ever compensate for having one or two more ports than conventional c-
VATS is also debatable. Only time will tell whether any one strategy is better than the 
others. 
These are just a few examples of the many variations on a theme of VATS lobectomy that 
exist today. Describing them is just meant to illustrate that the strict modern definition of 
this operation can still accommodate a range of different interpretations. A sage Chinese 
leader once famously said: “It doesn’t matter if the cat is black or white as long as it catches 
mice”. In a similar way, surgeons should be free to experiment with various technique 
details to find one suiting their own styles, provided the core principles of VATS lobectomy 
are adhered to and ensure the patient benefits from the minimally invasive approach. 
Regardless of the exact details of the operation used, patients today can expect rapid 
recovery after a VATS lobectomy (Whitson et al, 2008; Yan et al, 2009; Rueth & Andrade, 
2010; Scott et al, 2010). Data collected around the world suggest that mortality is no higher 
than after open lobectomy, and morbidity rates (typically around 15-20%) are usually lower. 
Chest drain durations average around 4-5 days, and patients are generally discharged 
around 4-7 days after surgery. For an ultra-major operation that a mere 30 years ago had a 
mortality rate approaching 10% and a complication rate of almost 60% (Wilkins et al, 1978; 
Keagy et al, 1985), these modern figures achieved with VATS are commendable. 
9. Current challenges, emerging solutions 
Despite the current success and popularity of VATS lobectomy, there is no room for VATS 
surgeons to be complacent. For a start, VATS lobectomy can no longer claim to be the least 
traumatic mode of curative therapy for lung cancer. Today, ablative therapy (using radio-
frequency or microwave energy), stereotactic (‘cyberknife’) radiosurgery, and stereotactic 
body radiation therapy (SBRT) all have better claims for that title (Fernando et al, 2005; 
Pennathur et al, 2009; Crabtree et al, 2010). SBRT is now wholly claimed by Oncologists, and 
there is no guarantee that surgeons will gain control of ablative and cyberknife therapy. 
Regardless of the survival rates achievable with these new treatment modalities, to the lay 
patient they represent an astonishing option that may ‘treat’ cancer without requiring major 
surgery. Unless the surgical option is made more palatable for patients, there is no doubt 
that increasing numbers of patients who are marginally or even completely suitable for 
surgery may be tempted away from the operating room.  
To make VATS lobectomy even better, it is first necessary to appreciate that it is not perfect. 
First of all, despite the smaller wounds and avoidance of rib-spreading, VATS does not 
make lobectomy pain-free. It has been found that 52.9% of patients receiving VATS 
pleurodesis for pneumothorax (in which no rib-spreading is used) experience paresthetic 
chest wall discomforts which are distinct from classical localized wound pain (Sihoe et al, 
2004a). This reported post-operative ‘pain’ or paresthesia appears characterized by 
sensations of burning, aching, electrical and/or shock-like in quality – which are all typical 
of neuropathic pain (Sihoe et al, 2006). In a follow-up study, it was  shown that the incidence 
and nature of the paresthesia remains similar even if the level of surgical trauma is further 
reduced by performing needlescopic VATS (Sihoe et al, 2005). VATS reduced pain 
compared to thoracotomy, but was itself still associated with a certain level of neuropathic 
injury. This injury is most likely caused by the torquing of the video-thoracoscope and 
instruments at the ports during surgery, and by the placement of a chest tube that is kept for 
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a few days post-operative. Both of these mechanisms contribute to a degree of intercostals 
nerve trauma. With this in mind, the surgeon can not only attempt to minimize intra-
operative torquing and remove chest tubes at the earliest opportunity, but he/she can also 
use pharmaco-therapy aimed specifically at treating neuropathic pain. At least one study 
has now shown that use of Gabapentin – a drug previously used to treat trigeminal and 
post-herpetic neuralgia – may be effective in alleviating post-operative pain after thoracic 
surgery (Sihoe et al, 2006). The author now frequently prescribes Gabapentin to patients 
after VATS lobectomy who experience paresthetic discomforts that are distinct from their 
sharp, localized wound pain. 
To combat pain, another strategy has been to make use of ‘pre-emptive’ analgesia. Some 
studies now suggest that a painful stimulus can ‘sensitize’ the central somatosensory 
pathways, and hence amplify the response to subsequent painful stimuli (Woolf, 1983; 
Woolf & Salter, 2000; Dahl & Moiniche, 2004). In theory, any treatment given before or 
during the operation that can prevent the original painful stimulus from activating this 
sensitization should therefore reduce the subsequent development and severity of post-
operative pain. A randomized trial in patients undergoing needlescopic VATS has now 
demonstrated that giving local anesthesia at the ports sites prior to making the surgical 
incisions can significantly reduce post-operative pain for up to a week after surgery (Sihoe 
et al, 2007). In this author’s practice, this concept has been combined with the use of regional 
neural blockade. In VATS lobectomy patients, a bolus paravertebral blockade using 
bupivicaine is routinely given after induction of general anesthesia and prior to starting the 
surgical operation. 
Besides pain, the most common complication seen after VATS lobectomy today is air 
leakage. With the reduced pain, earlier mobilization and better preserved lung function after 
VATS lobectomy, traditionally common respiratory complications such as atelectasis are 
increasingly rare. Instead, parenchymal air leakage is not something that is directly 
influenced by the size of the wounds or non-use of rib-spreading. As a result, air leak rates 
after VATS lobectomy are generally no different than after open lobectomy. Air leakage is 
not only the most prevalent postoperative complication after a lobectomy today, it is also 
the single most common reason for an extended length of hospitalization (Abolhoda et al, 
1998). Air leaks occur in up to 58% of patients after a lobectomy, and can persist for 5 days 
or more in 15-18% of patients (Brunelli & Fianchini, 1999; Isowa et al, 2002; Okereke et al, 
2005). Traditionally, if a parenchymal air leak is detected on-table, a variety of surgical 
techniques can be used to repair it. These include suturing, pleural tent creation, and so on. 
All of these techniques are possible with VATS, but not necessarily easy to perform given 
the small ports. Surgical sealants were a potentially easy-to-use solution and previous 
studies have shown that sealants may help reduce air leaks (Tansley et al, 2006; D’Andrilli et 
al, 2009). However, for a long time there was no effective means of delivery into the chest 
via the small VATS wounds. Fortunately, the rise of VATS lobectomy has been paralleled by 
the development of surgical sealant technology. Modern surgical sealants can now be 
readily aerosolized and delivered via dedicated endoscopic spray applicators. These make 
them eminently suitable for use in treating on-table air leaks during VATS. In a recent study 
looking at the endoscopic spray application of fibrin for on-table air leaks detected during 
VATS lobectomy, use of fibrin sealant significantly reduced air leak incidence, chest drain 
durations and lengths of hospital stay (Sihoe et al, 2009). A simple and effective solution for 
VATS lobectomy’s last remaining Achilles’ heels is therefore now emerging.  
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Fig. 4. The latest endoscopic spray applicators allow precise, even and easy delivery of 
flowable sealants to sites of parenchymal air leak – even via small VATS ports. Evidence is 
gradually accumulating that support an emerging role for such sealants in selected patients 
after VATS lobectomy. 
It is no use only improving the operation itself if the peri-operative care is not developed to 
complement the advances. In many traditional thoracic surgery centers, clinical 
management protocols already exist for how to manage a lung cancer patient who has 
received lobectomy. In the early days of VATS in Hong Kong, it was noticed that nursing 
and allied healthcare staff were still managing VATS lobectomy patients according to 
protocols designed years before for open thoracotomy patients. Mobilization and 
rehabilitation schedules were slow to take into account the slower recovery of thoracotomy 
patients, and this meant that VATS patients could not reap the full benefits of the newer 
minimally invasive approach. Over the past several years, the entire clinical pathway has 
been re-written in the author’s center in Hong Kong to fully complement VATS (Sihoe et al, 
2008). The analgesic regime has been revised to reduce the use of opiates – which are both 
unnecessary given the reduced pain with VATS, and detrimental because the sedation and 
dizziness caused could delay patient mobilization. In the new VATS pathway, patients are 
mobilization fully within 24 hours of surgery. Physiotherapy is implemented earlier and 
more aggressively. Chest drain removal is also expedited. Even post-operative 
investigations, when a patient opens his/her bowels, and schedules for meeting the 
patient’s relatives are included in the overall clinical pathway package. The literally dozens 
of items of changes have significantly improved the recovery process of VATS lobectomy 
patients. Since its implementation, chest drain durations, lengths of hospital stay, rates of 
complications, and rates of re-admission have all dropped significantly. The lesson learned 
is that improving operative surgical performance alone must be complemented by 
appropriate improvements in the ancillary services to bring out the full potential of VATS. 
However, in the view of this author, using all the above measures to improve surgical 
outcomes for the individual patient is not the ultimate goal for VATS. Benefiting the individual 
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patient alone will not ensure the survival of VATS lobectomy in the face of future challenges. 
Instead, the reduction of morbidity for individual patients must be translated into lowering of 
thresholds for surgery. If the surgery itself is causing fewer complications and pain, then 
presumably it can now be offered to patients for whom surgery was previously thought to be 
‘too high risk’. If this is achieved, then surgery – the only widely established ‘cure’ for early-
stage lung cancer – can reach a larger proportion of the population. ‘Marginal’ surgical 
candidates can be offered curative operations instead of compromised therapy (including 
SBRT) that have only limited chances of achieving tumor eradication. 
To this end, some encouraging studies are already emerging. In one study from Hong Kong, 
VATS lobar and sublobar resection with curative intent was performed in patients with 
forced expiratory volume in one second on spirometry (FEV1) of <0.8L and/or <50% 
predicted (Garzon et al, 2006). Patients with such poor lung function would have 
traditionally been refused any form of curative major lung surgery. However, when VATS 
was used in this cohort, there was no in-hospital mortality and only a 20% rate of 
respiratory complications. After a median follow-up of 15 months, only 4% of all patients 
died of respiratory complications and none of the survivors required home oxygen. In a 
separate study, VATS and thoracotomy approaches for lung resection with curative intent 
were compared in lung cancer patients aged over 75 years (Staffa et al, 2010). VATS 
achieved the same recurrence-free survival rates as open thoracotomy, but at the same time 
reduced in-hospital complication rates, lengths of post-operative hospital stay, post-
discharge complication rates, and also persisting pain at 2 weeks after surgery. Such studies 
suggest that the list of contra-indications for lung cancer surgery may need to be revised if 
VATS can be offered. This can potentially offer a hope of effective cure for lung cancer 
patients previously denied surgery.  
10. Future directions 
Looking ahead, it is already possible to foresee where the continuing evolution of VATS 
lobectomy may be headed in the near future. Most of these trends are being driven by rapid 
technological advances. The rise of Endobronchial Ultrasonography (EBUS) may be one of 
these (Kurimoto & Miyazawa, 2004). With a minute ultrasound probe positioned at the tip 
of a flexible bronchoscope, the endoscopist can see ‘through’ the airway walls into the 
surrounding mediastinal and hilar structures and attempt biopsy of lymph nodes or other 
tissues. While EBUS is still predominantly being performed by respirologists, it may still 
play an important role in thoracic surgery. EBUS can be used for routine mediastinal nodal 
screening in the operating room immediately prior to embarking on a VATS lobectomy. This 
approach may overcome the aversion of many thoracic surgeons in offering routine 
mediastinal screening because of the relative morbidity caused by conventional 
mediastinoscopy. It is also the strongest argument in favor of surgeons taking responsibility 
for performing EBUS, as surgeons can offer one-stop staging plus therapeutic surgery in the 
operating (as opposed to staging by the respirologist and then a separate therapeutic 
procedure by the surgeon). EBUS may also be useful in patients with suspected N2 nodal 
metastasis who may be candidates for the strategy of upfront neoadjuvant therapy followed 
by surgery. If EBUS can confirm the metastasis without needing mediastinoscopy, then the 
mediastinoscopy can be ‘saved’ until after the neoadjuvant therapy is completed and used 
for re-staging purposes. 
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Fig. 5. Using a new portable digital chest drain system (solid arrow), a patient is typically 
able to mobilize freely within 12-18 hours of a VATS lobectomy. With an inbuilt suction 
system, the patient’s mobility is unrestricted even if suction is required for any reason. 
When the patient returns to the bedside, the digital drain can simply be placed onto a dock 
(dotted arrow) which recharges its batteries.  Besides promoting post-operative recovery for 
the patient, the digital drain provides the surgeon an objective, quantified measurement of 
any air leak via the chest tube.  Preliminary clinical evidence suggests that this may improve 
consistency and hence efficiency of air leak management after VATS lobectomy. 
Another emerging technological advance are the new portable digital chest drain systems 
that have come onto the market over the last few years. Traditional water seal chest drain 
systems are clumsy and unwieldy. They require attention not to be lifted above the chest 
level, not to be accidentally tipped over, and not to have the water seal evaporated 
unnoticed. If suction is required for any reason, connection to an external suction source also 
effectively ties the patient down like a ball-&-chain restraint. When VATS lobectomy is 
performed, it is particularly frustrating to see post-operative mobility being restricted not by 
the surgery but by the use of an old-fashioned chest drain. A modern digital system such as 
the Medela Thopaz (Medela AG, Switzerland) does away with a water seal altogether, and 
comes with an inbuilt suction system that maintains a constant, user-set negative pleural 
pressure without need for any external connection. The result is a compact, portable chest 
drain that permits complete patient mobility after lobectomy. This complements the early 
mobility afforded by VATS lobectomy well, and ensures the patient can fully benefit from 
the minimally invasive approach. An initial survey of patients and nurses on the use of the 
portable device has already produced preliminary confirmation that chest drain handling 
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and patient mobility are improved compared to conventional water seal systems (Sihoe & 
Yeung, 2011). Perhaps more importantly, it has also been shown that use of the digital air 
flow monitor on a digital system such as the Thopaz can accurately and objectively measure 
post-operative air leaks after lung surgery (Varela et al, 2009). A study from Hong Kong has 
already demonstrated that the greater consistency in monitoring air leaks can be translated 
into more decisive, confident post-operative chest drain management resulting in shortened 
chest drain durations and lengths of hospital stay (Yeung & Sihoe, 2010). The combination of 
improved patient recovery and more effective air leak management should prove attractive 
to surgeons looking to maximize the potential of VATS lobectomy in improving outcomes. 
In the past few years, increasing numbers of abstracts on the use of digital drain systems 
have been presented at major thoracic surgical conferences in Asia and Europe, reflecting 
the growing importance of this new technology. 
Of course, the one surgical technology capturing the most attention amongst surgeons and 
the lay public in recent years is undoubtedly that of robot assisted surgery. The da Vinci 
robotic surgical system (Surgical Intuitive, Mountain View, CA) allows the surgeon at a 
console to ‘remote control’ robot limbs inserted into the patient to perform the operation. 
The purported advantages of using robot assistance include precise tremor-free 
manipulations, 3D binocular visualization, excellent ergonomics for the surgeon, and the 
ability of the robotic arms to minimize torquing of the instruments at each working port 
(Melfi et al, 2002). Early published series have demonstrated the safety and feasibility of 
robot assisted surgery within the thorax, even for major lung resection (Varonesi et al, 2010). 
However, good results have so far mainly been reported by a small number of specialist 
centers with particular experience using robots, and a couple of recognized drawbacks still 
remain. The first issue is the complete absence of tactile feedback throughout the operation 
(D’Amico, 2006). For many operations, the visual information can partly compensate for 
this. However, tactile feedback is often crucial in thoracic surgery, and whether current 
robotic technology can consistently address this fundamental limitation during the intricate 
dissections in the course of a lobectomy remains to be fully proven. The other disadvantage 
of robot assisted surgery is the costs – both of the initial outlay for the advanced hardware 
and of the bespoke instruments and consumables that must be purchased for each 
operation. Because of the very low morbidity rates and excellent outcomes with 
conventional VATS, it may prove difficult – if not impossible – to ever demonstrate any 
significant superiority of the robot system over VATS. Conceptually, it is hard to see how a 
robot assisted lobectomy using four ports can ever be convincingly proven to cause less 
trauma than a typical c-VATS lobectomy using 3 ports. Consequently, for the foreseeable 
future at least, making a compelling case for robot assisted surgery in terms of cost-
effectiveness will very likely prove futile.  
In the inevitably upcoming debates over the relative merits of robot assisted surgery and 
VATS, it is worth making one telling observation. Many (but not all) reports on robot assisted 
thoracic surgery appear to have originated from centers that are not generally associated with 
major well-developed VATS lobectomy programs. Even the authors of leading published 
reports on robot assisted lobectomy acknowledge that their standard approach to lung 
lobectomy was through thoracotomy, not VATS (Varonesi et al, 2010). Very few of the 
established VATS lobectomy centers have switched to using the robot. This peculiar 
phenomenon suggests that for surgeons used to open surgery, the very intuitive and user-
friendly robot systems interface may be easier to master than the different set of hand-eye 
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skills demanded by VATS lobectomy. This provides non-VATS surgeons an excellent route 
into the world of minimally invasive thoracic surgery. However, for those who have mastered 
VATS lobectomy, the robot systems do not seem to offer any advantage or incentive to switch 
(Swanson, 2010). Again, only time will tell whether the robot systems are a passing fad or an 
emerging viable alternative approach to lung surgery as VATS once was. 
Whatever the potential of robot systems, there is also another possible (and much simpler) 
direction for minimally invasive thoracic surgery: needlescopic VATS. In this technique, 
video-thoracoscopes and instruments of only 2-3 mm diameter are used, requiring much 
smaller ports than the typical 5-15mm ports used in conventional VATS. The wounds are 
typically so small that only barely detectable ‘pinpoint’ scars remain after surgery – leading 
to term ‘needlescopic’ VATS. The principle is that if VATS can improve on open 
thoracotomy by using smaller wounds, then needlescopic VATS should give better 
outcomes than conventional VATS by using even smaller wounds. Compared to robot 
assisted surgery, this approach uses far smaller ports and should be much cheaper. 
Needlescopic VATS has already been used for a variety of diagnostic and simple therapeutic 
procedures, such as sympathectomy for palmar hyperidrosis (Yim et al, 2000b; Lazopoulos 
et al, 2002; Sihoe et al, 2004b). More recently, needlescopic VATS has been used for 
pleurodesis surgery in the management of pneumothorax, achieving equivalent efficacy as 
conventional VATS but with less pain and faster recovery (Sihoe & Lin, 2011). As mentioned 
above, some VATS surgeons have already begun using 3-5mm instruments in their 
lobectomy operations, but only as a supplement to conventional VATS instruments (Gossot, 
2008). With the potential benefits of the needlescopic approach, it may just be a matter of 
time before we witness reports of a totally needlescopic VATS lobectomy. 
11. Conclusions 
When VATS lobectomy was first conceived during the heyday of minimally invasive surgery, 
the pioneers had relatively little understanding of how the approach would benefit patients 
other than that smaller wounds would create less pain. A good number of reports documented 
that VATS did indeed cause less pain than traditional open surgery via thoracotomy. 
However, after the initial flurry of promising results, subsequent reports began painting a 
rather less flattering picture of VATS, suggesting that VATS may not be as advantageous as 
first hoped. In the quest to address these disappointing results, several important truths 
emerged. Firstly, the importance of clearly defining what VATS lobectomy is or is not was 
realized. Thus clearly defined, it became possible to not only reaffirm that complete VATS 
does improve patient outcomes, but also to better appreciate why VATS does this. Secondly, 
the use of standardized, objective and reproducible outcome measures are now providing a far 
more reliable picture of how much VATS can help the patient receiving lung surgery. This has 
not only established the role of VATS in lung cancer management, but raised the standards of 
outcome measurement in thoracic surgery as a whole. Thirdly, the pursuit of answers to 
questions put forth by critics of VATS has trained VATS surgeons to focus on what the key 
benefits to be gained from minimally invasive surgery really are. This in turn has led to 
continued efforts to advance those benefits for patients, culminating in many clinical and 
technological innovations to improve the state of the art. 
It behoves the VATS surgeon to learn the lessons of the first two decades of VATS 
lobectomy. The evolution of VATS is an ongoing process. Challenges to the role of VATS 
lobectomy will never cease to emerge. Application of the enterprise and diligence of the 
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VATS pioneers is necessary to constantly test and evolve the practice of thoracic surgery, 
ensuring it remains as relevant to patients in the future as it is today. 
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